WHAT HAVE WE EXPERIENCED WITH COVID-19 IN PATIENTS WITH HEMATOLOGICAL DISORDERS?

Objective: Patients with cancer are considered highly vulnerable to the COVID-19 disease. However, there are still few data in hematologic patients. Some small studies have shown a high mortality on patients with hematologic malignancies and COVID-19. In this study we aim to report a single center e...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Simge ERDEM, Metban MASTANZADE, Mustafa Murat OZBALAK, Dilek Ozden OZLUK, Tarık Onur TIRYAKI, Beyza OLUK, Ipek YONAL HINDILERDEN, Mustafa Nuri YENEREL, Meliha NALCACI, Sevgi KALAYOGLU BESISIK, Sevda SERT EKINCI, Tufan TUKEK
Formato: article
Lenguaje:EN
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://doaj.org/article/46923d1fb2504c958a9c7ce3a16c01f9
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares